Julian R. Molina
Department of Oncology
Mayo Clinic College of Medicine
Rochester
Minnesota 55905
USA
Name/email consistency: high
- Evaluation of lapatinib and topotecan combination therapy: tissue culture, murine xenograft, and phase I clinical trial data. Molina, J.R., Kaufmann, S.H., Reid, J.M., Rubin, S.D., Gálvez-Peralta, M., Friedman, R., Flatten, K.S., Koch, K.M., Gilmer, T.M., Mullin, R.J., Jewell, R.C., Felten, S.J., Mandrekar, S., Adjei, A.A., Erlichman, C. Clin. Cancer Res. (2008)
- Pralatrexate, a dihydrofolate reductase inhibitor for the potential treatment of several malignancies. Molina, J.R. IDrugs (2008)
- Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Molina, J.R., Yang, P., Cassivi, S.D., Schild, S.E., Adjei, A.A. Mayo Clin. Proc. (2008)
- Primary salivary gland-type lung cancer: spectrum of clinical presentation, histopathologic and prognostic factors. Molina, J.R., Aubry, M.C., Lewis, J.E., Wampfler, J.A., Williams, B.A., Midthun, D.E., Yang, P., Cassivi, S.D. Cancer (2007)
- Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases. Molina, J.R., Quevedo, J.F., Furth, A.F., Richardson, R.L., Zincke, H., Burch, P.A. Cancer (2007)
- Advances in chemotherapy of non-small cell lung cancer. Molina, J.R., Adjei, A.A., Jett, J.R. Chest (2006)
- The Ras/Raf/MAPK pathway. Molina, J.R., Adjei, A.A. J. Thorac. Oncol (2006)
